Immunotherapy of brain metastases: breaking a “dogma”

Immunotherapy of brain metastases: breaking a “dogma”

Abstract Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check-point(s) across a wide range of tumor types, pati...

Full description

Bibliographic Details
Main Authors: Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre, Michele Maio
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Brain metastases
Immune checkpoint(s)
Cancer immunotherapy
Lung cancer
Magnetic resonance imaging
Melanoma
Online Access:http://link.springer.com/article/10.1186/s13046-019-1426-2

Internet

http://link.springer.com/article/10.1186/s13046-019-1426-2

Similar Items